Investing

Investing Cash Flow

Kailera Therapeutics Investing Cash Flow increased by 142.0% to $22.85M in Q1 2026 compared to the prior quarter.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2025
Last reportedQ1 2026May 26, 2026

How to read this metric

A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.

Detailed definition

This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...

Peer comparison

Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.

Metric ID: net_cash_from_investing

Historical Data

2 periods
 Q1 '25Q1 '26
Value-$54.44M$22.85M
QoQ Change—+142.0%
YoY Change—+142.0%
Range-$54.44M – $22.85M
Avg YoY Growth+142.0%
Median YoY Growth+142.0%

Investing Cash Flow at Other Companies

CF Industries logo
CF IndustriesCFView metric
CF Industries logo
CF IndustriesCFView metric
Brookfield Asset Management logo
Brookfield Asset ManagementBAMView metric
Iron Mountain logo
Iron MountainIRMView metric
Cboe Global Markets logo
Cboe Global MarketsCBOEView metric
T Rowe Price Group logo
T Rowe Price GroupTROWView metric

Frequently Asked Questions

What is Kailera Therapeutics 's investing cash flow?
Kailera Therapeutics (KLRA) reported investing cash flow of $22.85M in Q1 2026.
What does investing cash flow mean?
The net amount of cash spent on or received from investing activities.